Cargando…

The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis

OBJECTIVES: The main aim of this systematic review and meta-analysis was to assess the proportion of confirmed COVID-19 patients with Clostridioides difficile infection (CDI) and to describe risk factors and outcome of these patients. METHODS: MEDLINE and Cochrane Central Register of Controlled Tria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granata, Guido, Petrosillo, Nicola, Al Moghazi, Samir, Caraffa, Emanuela, Puro, Vincenzo, Tillotson, Glenn, Cataldo, Maria Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616765/ https://www.ncbi.nlm.nih.gov/pubmed/34843959 http://dx.doi.org/10.1016/j.anaerobe.2021.102484

Ejemplares similares

Clostridioides difficile Infection: A Room for Multifaceted Interventions
por: Petrosillo, Nicola, et al.
Publicado: (2020)

Novel Antimicrobials for the Treatment of Clostridium difficile Infection
por: Petrosillo, Nicola, et al.
Publicado: (2018)

Clostridioides difficile and Enterococci’s Interplay in the Human Gut: Bacterial Alliance or Competition? A Systematic Literature Review
por: Granata, Guido, et al.
Publicado: (2023)

High Serum Levels of Toxin A Correlate with Disease Severity in Patients with Clostridioides difficile Infection
por: Granata, Guido, et al.
Publicado: (2021)

Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
por: Maraolo, Alberto Enrico, et al.
Publicado: (2022)

Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review
por: Rindi, Lorenzo Vittorio, et al.
Publicado: (2022)

Clostridioides difficile Infection: A Never-Ending Challenge
por: Petrosillo, Nicola
Publicado: (2022)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Transitions of care in Clostridioides difficile infection: a need of the hour
por: Khanna, Sahil, et al.
Publicado: (2022)

Introduction to the Special Issue on Clostridioides difficile
por: Granata, Guido, et al.
Publicado: (2021)

Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Role of the microbiome in essential metabolism in the human gut and its implications for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
por: Granata, Guido, et al.
Publicado: (2021)

Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases
por: Tonziello, Gilda, et al.
Publicado: (2019)

Streptococcus intermedius Brain Abscess with Lung Abscess and Aortic Valve Endocarditis: A Case Report and Literature Review
por: Gavaruzzi, Francesca, et al.
Publicado: (2023)

The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid)
por: Granata, Guido, et al.
Publicado: (2020)

Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2023)

Systematic Literature Review on Burden of Clostridioides difficile Infection in India
por: Ghia, Canna J, et al.
Publicado: (2021)

Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections
por: Orenstein, Robert, et al.
Publicado: (2023)

The Clinical Burden of Clostridioides difficile in Ontario, Canada
por: Pereira, Jennifer A, et al.
Publicado: (2019)

Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis
por: Reveles, Kelly R., et al.
Publicado: (2023)

Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life
por: Garey, Kevin W, et al.
Publicado: (2023)

Bezlotoxumab in Patients with a Primary Clostridioides difficile Infection: A Literature Review
por: Granata, Guido, et al.
Publicado: (2022)

Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020
por: Sandhu, Avnish, et al.
Publicado: (2020)

Clostridium difficile--a moving target
por: Tillotson, Glenn S., et al.
Publicado: (2011)

Burden of Clostridium (Clostridioides) difficile Infection among Patients in Western Asia: A Systematic Review and Meta-Analysis
por: MALEKZADEGAN, Yalda, et al.
Publicado: (2019)

236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities
por: Tillotson, Glenn S, et al.
Publicado: (2022)

Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent Clostridioides difficile Infection in Older Adults With Underlying Comorbidities
por: Tillotson, Glenn, et al.
Publicado: (2022)

Salmonella Hessarek Gastroenteritis with Bacteremia: A Case Report and Literature Review
por: Chinello, Pierangelo, et al.
Publicado: (2020)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”
por: Cataldo, Maria Adriana, et al.
Publicado: (2020)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
por: Braae, Uffe Christian, et al.
Publicado: (2020)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
por: Finn, Elaine, et al.
Publicado: (2021)

Association of COVID-19 case fatality rate with disease burden: an ecological analysis in Italy during the first wave
por: Timelli, Laura, et al.
Publicado: (2021)

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective
por: Hocking, Lucy, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis
por: Muhammad, Aziz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_86dc29tumn7p4pr3ii9na4ovti